nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Dacarbazine—sarcoma	0.589	0.762	CbGbCtD
Meloxicam—PTGS2—Etoposide—sarcoma	0.0467	0.0605	CbGbCtD
Meloxicam—PTGS1—Etoposide—sarcoma	0.0395	0.0511	CbGbCtD
Meloxicam—CYP3A4—Thiotepa—sarcoma	0.0341	0.0441	CbGbCtD
Meloxicam—CYP2C8—Etoposide—sarcoma	0.0228	0.0295	CbGbCtD
Meloxicam—CYP3A4—Mitoxantrone—sarcoma	0.0146	0.019	CbGbCtD
Meloxicam—CYP3A4—Vincristine—sarcoma	0.0101	0.0131	CbGbCtD
Meloxicam—CYP3A4—Etoposide—sarcoma	0.00924	0.012	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—sarcoma	0.0063	0.00816	CbGbCtD
Meloxicam—PTGS2—periosteum—sarcoma	0.00297	0.0592	CbGeAlD
Meloxicam—PTGS2—leg—sarcoma	0.00237	0.0472	CbGeAlD
Meloxicam—PGD—mammary gland—sarcoma	0.0022	0.0439	CbGeAlD
Meloxicam—PTGS2—hindlimb—sarcoma	0.00211	0.0421	CbGeAlD
Meloxicam—PTGS2—cartilage tissue—sarcoma	0.00208	0.0415	CbGeAlD
Meloxicam—PTGS2—appendage—sarcoma	0.00181	0.0361	CbGeAlD
Meloxicam—PGD—myometrium—sarcoma	0.00156	0.0312	CbGeAlD
Meloxicam—PGD—seminal vesicle—sarcoma	0.00141	0.0282	CbGeAlD
Meloxicam—PGD—hematopoietic system—sarcoma	0.00134	0.0268	CbGeAlD
Meloxicam—PGD—connective tissue—sarcoma	0.00129	0.0258	CbGeAlD
Meloxicam—PGD—smooth muscle tissue—sarcoma	0.00118	0.0236	CbGeAlD
Meloxicam—PGD—skin of body—sarcoma	0.00117	0.0233	CbGeAlD
Meloxicam—PTGS1—endothelium—sarcoma	0.00114	0.0228	CbGeAlD
Meloxicam—CYP2C8—mammary gland—sarcoma	0.00114	0.0227	CbGeAlD
Meloxicam—PTGS2—endothelium—sarcoma	0.00109	0.0218	CbGeAlD
Meloxicam—PGD—cardiac atrium—sarcoma	0.00102	0.0203	CbGeAlD
Meloxicam—PGD—uterus—sarcoma	0.00101	0.0202	CbGeAlD
Meloxicam—CYP2C9—mammary gland—sarcoma	0.00101	0.0201	CbGeAlD
Meloxicam—ABCC4—hematopoietic system—sarcoma	0.000955	0.019	CbGeAlD
Meloxicam—PGD—lymphoid tissue—sarcoma	0.000945	0.0188	CbGeAlD
Meloxicam—PGD—tendon—sarcoma	0.000888	0.0177	CbGeAlD
Meloxicam—PGD—bone marrow—sarcoma	0.00086	0.0172	CbGeAlD
Meloxicam—PGD—testis—sarcoma	0.000735	0.0147	CbGeAlD
Meloxicam—ABCC4—uterus—sarcoma	0.000721	0.0144	CbGeAlD
Meloxicam—PGD—liver—sarcoma	0.000695	0.0139	CbGeAlD
Meloxicam—CYP2C8—hematopoietic system—sarcoma	0.000693	0.0138	CbGeAlD
Meloxicam—ABCC4—tendon—sarcoma	0.000632	0.0126	CbGeAlD
Meloxicam—PTGS2—myometrium—sarcoma	0.000626	0.0125	CbGeAlD
Meloxicam—CYP2C9—hematopoietic system—sarcoma	0.000616	0.0123	CbGeAlD
Meloxicam—ABCC4—bone marrow—sarcoma	0.000612	0.0122	CbGeAlD
Meloxicam—PTGS2—embryo—sarcoma	0.000602	0.012	CbGeAlD
Meloxicam—PTGS1—seminal vesicle—sarcoma	0.000591	0.0118	CbGeAlD
Meloxicam—PTGS2—seminal vesicle—sarcoma	0.000565	0.0113	CbGeAlD
Meloxicam—PTGS1—hematopoietic system—sarcoma	0.000562	0.0112	CbGeAlD
Meloxicam—PTGS1—connective tissue—sarcoma	0.000541	0.0108	CbGeAlD
Meloxicam—PTGS2—hematopoietic system—sarcoma	0.000537	0.0107	CbGeAlD
Meloxicam—PGD—lymph node—sarcoma	0.000533	0.0106	CbGeAlD
Meloxicam—ABCC4—testis—sarcoma	0.000523	0.0104	CbGeAlD
Meloxicam—PTGS2—connective tissue—sarcoma	0.000517	0.0103	CbGeAlD
Meloxicam—PTGS1—smooth muscle tissue—sarcoma	0.000495	0.00987	CbGeAlD
Meloxicam—ABCC4—liver—sarcoma	0.000495	0.00986	CbGeAlD
Meloxicam—PTGS1—skin of body—sarcoma	0.000489	0.00974	CbGeAlD
Meloxicam—PTGS2—smooth muscle tissue—sarcoma	0.000473	0.00943	CbGeAlD
Meloxicam—CYP3A4—hematopoietic system—sarcoma	0.000469	0.00936	CbGeAlD
Meloxicam—PTGS2—skin of body—sarcoma	0.000467	0.00931	CbGeAlD
Meloxicam—PTGS1—cardiac atrium—sarcoma	0.000427	0.00851	CbGeAlD
Meloxicam—PTGS1—uterus—sarcoma	0.000425	0.00846	CbGeAlD
Meloxicam—PTGS2—uterus—sarcoma	0.000406	0.00809	CbGeAlD
Meloxicam—CYP2C8—testis—sarcoma	0.00038	0.00757	CbGeAlD
Meloxicam—ABCC4—lymph node—sarcoma	0.000379	0.00756	CbGeAlD
Meloxicam—PTGS2—lymphoid tissue—sarcoma	0.000378	0.00754	CbGeAlD
Meloxicam—PTGS1—tendon—sarcoma	0.000372	0.00741	CbGeAlD
Meloxicam—CYP2C8—liver—sarcoma	0.000359	0.00716	CbGeAlD
Meloxicam—PTGS2—tendon—sarcoma	0.000356	0.00709	CbGeAlD
Meloxicam—PTGS2—bone marrow—sarcoma	0.000344	0.00687	CbGeAlD
Meloxicam—CYP2C9—liver—sarcoma	0.000319	0.00636	CbGeAlD
Meloxicam—PTGS1—testis—sarcoma	0.000308	0.00614	CbGeAlD
Meloxicam—PTGS2—liver—sarcoma	0.000278	0.00555	CbGeAlD
Meloxicam—CYP3A4—liver—sarcoma	0.000243	0.00485	CbGeAlD
Meloxicam—PTGS1—lymph node—sarcoma	0.000223	0.00445	CbGeAlD
Meloxicam—PTGS2—lymph node—sarcoma	0.000213	0.00425	CbGeAlD
Meloxicam—Dyspnoea—Etoposide—sarcoma	0.000169	0.00095	CcSEcCtD
Meloxicam—Somnolence—Etoposide—sarcoma	0.000168	0.000947	CcSEcCtD
Meloxicam—Angina pectoris—Doxorubicin—sarcoma	0.000168	0.000946	CcSEcCtD
Meloxicam—Hypersensitivity—Mitoxantrone—sarcoma	0.000167	0.000944	CcSEcCtD
Meloxicam—Asthenia—Vincristine—sarcoma	0.000167	0.000943	CcSEcCtD
Meloxicam—Vomiting—Thiotepa—sarcoma	0.000167	0.000943	CcSEcCtD
Meloxicam—Infestation NOS—Epirubicin—sarcoma	0.000166	0.000936	CcSEcCtD
Meloxicam—Drowsiness—Epirubicin—sarcoma	0.000166	0.000936	CcSEcCtD
Meloxicam—Infestation—Epirubicin—sarcoma	0.000166	0.000936	CcSEcCtD
Meloxicam—Vomiting—Dactinomycin—sarcoma	0.000166	0.000936	CcSEcCtD
Meloxicam—Rash—Thiotepa—sarcoma	0.000166	0.000935	CcSEcCtD
Meloxicam—Bronchitis—Doxorubicin—sarcoma	0.000166	0.000934	CcSEcCtD
Meloxicam—Dermatitis—Thiotepa—sarcoma	0.000166	0.000934	CcSEcCtD
Meloxicam—Headache—Thiotepa—sarcoma	0.000165	0.000929	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000165	0.000928	CcSEcCtD
Meloxicam—Rash—Dactinomycin—sarcoma	0.000165	0.000928	CcSEcCtD
Meloxicam—Decreased appetite—Etoposide—sarcoma	0.000164	0.000926	CcSEcCtD
Meloxicam—Pancytopenia—Doxorubicin—sarcoma	0.000164	0.000923	CcSEcCtD
Meloxicam—Renal failure—Epirubicin—sarcoma	0.000163	0.00092	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Etoposide—sarcoma	0.000163	0.00092	CcSEcCtD
Meloxicam—Asthenia—Mitoxantrone—sarcoma	0.000163	0.000919	CcSEcCtD
Meloxicam—Fatigue—Etoposide—sarcoma	0.000163	0.000918	CcSEcCtD
Meloxicam—Stomatitis—Epirubicin—sarcoma	0.000162	0.000913	CcSEcCtD
Meloxicam—Jaundice—Epirubicin—sarcoma	0.000162	0.000913	CcSEcCtD
Meloxicam—Constipation—Etoposide—sarcoma	0.000162	0.000911	CcSEcCtD
Meloxicam—Pain—Etoposide—sarcoma	0.000162	0.000911	CcSEcCtD
Meloxicam—Urinary tract infection—Epirubicin—sarcoma	0.000162	0.00091	CcSEcCtD
Meloxicam—Conjunctivitis—Epirubicin—sarcoma	0.000162	0.00091	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00016	0.000903	CcSEcCtD
Meloxicam—Diarrhoea—Vincristine—sarcoma	0.00016	0.0009	CcSEcCtD
Meloxicam—Sweating—Epirubicin—sarcoma	0.000159	0.000898	CcSEcCtD
Meloxicam—Pollakiuria—Doxorubicin—sarcoma	0.000159	0.000898	CcSEcCtD
Meloxicam—Haematuria—Epirubicin—sarcoma	0.000158	0.000893	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—sarcoma	0.000157	0.000887	CcSEcCtD
Meloxicam—Hepatobiliary disease—Epirubicin—sarcoma	0.000157	0.000885	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—sarcoma	0.000157	0.000884	CcSEcCtD
Meloxicam—Nausea—Thiotepa—sarcoma	0.000156	0.000881	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—sarcoma	0.000156	0.000879	CcSEcCtD
Meloxicam—Sinusitis—Epirubicin—sarcoma	0.000156	0.000878	CcSEcCtD
Meloxicam—Feeling abnormal—Etoposide—sarcoma	0.000156	0.000878	CcSEcCtD
Meloxicam—Diarrhoea—Mitoxantrone—sarcoma	0.000156	0.000876	CcSEcCtD
Meloxicam—Nausea—Dactinomycin—sarcoma	0.000155	0.000874	CcSEcCtD
Meloxicam—Agranulocytosis—Epirubicin—sarcoma	0.000155	0.000874	CcSEcCtD
Meloxicam—Gastrointestinal pain—Etoposide—sarcoma	0.000155	0.000871	CcSEcCtD
Meloxicam—Dizziness—Vincristine—sarcoma	0.000154	0.00087	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—sarcoma	0.000154	0.000866	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—sarcoma	0.000154	0.000866	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—sarcoma	0.000154	0.000866	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000152	0.000859	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—sarcoma	0.000151	0.000852	CcSEcCtD
Meloxicam—Urticaria—Etoposide—sarcoma	0.00015	0.000846	CcSEcCtD
Meloxicam—Haemoglobin—Epirubicin—sarcoma	0.00015	0.000845	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—sarcoma	0.00015	0.000844	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—sarcoma	0.00015	0.000844	CcSEcCtD
Meloxicam—Rhinitis—Epirubicin—sarcoma	0.00015	0.000843	CcSEcCtD
Meloxicam—Body temperature increased—Etoposide—sarcoma	0.000149	0.000842	CcSEcCtD
Meloxicam—Abdominal pain—Etoposide—sarcoma	0.000149	0.000842	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—sarcoma	0.000149	0.000842	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—sarcoma	0.000149	0.000842	CcSEcCtD
Meloxicam—Haemorrhage—Epirubicin—sarcoma	0.000149	0.00084	CcSEcCtD
Meloxicam—Hepatitis—Epirubicin—sarcoma	0.000149	0.00084	CcSEcCtD
Meloxicam—Vomiting—Vincristine—sarcoma	0.000148	0.000836	CcSEcCtD
Meloxicam—Pharyngitis—Epirubicin—sarcoma	0.000148	0.000834	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—sarcoma	0.000147	0.00083	CcSEcCtD
Meloxicam—Urinary tract disorder—Epirubicin—sarcoma	0.000147	0.00083	CcSEcCtD
Meloxicam—Rash—Vincristine—sarcoma	0.000147	0.000829	CcSEcCtD
Meloxicam—Dermatitis—Vincristine—sarcoma	0.000147	0.000828	CcSEcCtD
Meloxicam—Oedema peripheral—Epirubicin—sarcoma	0.000147	0.000828	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—sarcoma	0.000147	0.000826	CcSEcCtD
Meloxicam—Connective tissue disorder—Epirubicin—sarcoma	0.000147	0.000826	CcSEcCtD
Meloxicam—Urethral disorder—Epirubicin—sarcoma	0.000146	0.000824	CcSEcCtD
Meloxicam—Headache—Vincristine—sarcoma	0.000146	0.000824	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—sarcoma	0.000145	0.000819	CcSEcCtD
Meloxicam—Vomiting—Mitoxantrone—sarcoma	0.000145	0.000814	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—sarcoma	0.000144	0.000813	CcSEcCtD
Meloxicam—Visual impairment—Epirubicin—sarcoma	0.000144	0.00081	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—sarcoma	0.000143	0.000808	CcSEcCtD
Meloxicam—Rash—Mitoxantrone—sarcoma	0.000143	0.000807	CcSEcCtD
Meloxicam—Dermatitis—Mitoxantrone—sarcoma	0.000143	0.000807	CcSEcCtD
Meloxicam—Headache—Mitoxantrone—sarcoma	0.000142	0.000802	CcSEcCtD
Meloxicam—Erythema multiforme—Epirubicin—sarcoma	0.000141	0.000795	CcSEcCtD
Meloxicam—Eye disorder—Epirubicin—sarcoma	0.000139	0.000785	CcSEcCtD
Meloxicam—Hypersensitivity—Etoposide—sarcoma	0.000139	0.000785	CcSEcCtD
Meloxicam—Tinnitus—Epirubicin—sarcoma	0.000139	0.000784	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—sarcoma	0.000139	0.000782	CcSEcCtD
Meloxicam—Nausea—Vincristine—sarcoma	0.000139	0.000781	CcSEcCtD
Meloxicam—Flushing—Epirubicin—sarcoma	0.000138	0.00078	CcSEcCtD
Meloxicam—Cardiac disorder—Epirubicin—sarcoma	0.000138	0.00078	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—sarcoma	0.000138	0.00078	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—sarcoma	0.000138	0.000778	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—sarcoma	0.000138	0.000778	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—sarcoma	0.000137	0.000772	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—sarcoma	0.000136	0.000768	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—sarcoma	0.000136	0.000766	CcSEcCtD
Meloxicam—Asthenia—Etoposide—sarcoma	0.000136	0.000764	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—sarcoma	0.000136	0.000764	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—sarcoma	0.000135	0.000763	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—sarcoma	0.000135	0.000762	CcSEcCtD
Meloxicam—Nausea—Mitoxantrone—sarcoma	0.000135	0.000761	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—sarcoma	0.000135	0.000759	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—sarcoma	0.000134	0.000757	CcSEcCtD
Meloxicam—Pruritus—Etoposide—sarcoma	0.000134	0.000754	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—sarcoma	0.000133	0.000751	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—sarcoma	0.000133	0.000749	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—sarcoma	0.000132	0.000743	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—sarcoma	0.000131	0.000736	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—sarcoma	0.000131	0.000735	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—sarcoma	0.00013	0.000732	CcSEcCtD
Meloxicam—Erythema—Epirubicin—sarcoma	0.00013	0.000732	CcSEcCtD
Meloxicam—Diarrhoea—Etoposide—sarcoma	0.000129	0.000729	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—sarcoma	0.000129	0.000727	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—sarcoma	0.000129	0.000725	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—sarcoma	0.000128	0.000722	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—sarcoma	0.000128	0.000722	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—sarcoma	0.000128	0.000721	CcSEcCtD
Meloxicam—Tension—Epirubicin—sarcoma	0.000127	0.000718	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—sarcoma	0.000127	0.000716	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—sarcoma	0.000126	0.000711	CcSEcCtD
Meloxicam—Back pain—Epirubicin—sarcoma	0.000126	0.000708	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—sarcoma	0.000125	0.000706	CcSEcCtD
Meloxicam—Dizziness—Etoposide—sarcoma	0.000125	0.000704	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—sarcoma	0.000125	0.000703	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—sarcoma	0.000125	0.000702	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—sarcoma	0.000124	0.000701	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—sarcoma	0.000123	0.000695	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—sarcoma	0.000122	0.00069	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—sarcoma	0.000122	0.000687	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—sarcoma	0.000121	0.000681	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—sarcoma	0.00012	0.000679	CcSEcCtD
Meloxicam—Vomiting—Etoposide—sarcoma	0.00012	0.000677	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—sarcoma	0.00012	0.000677	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—sarcoma	0.00012	0.000677	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—sarcoma	0.00012	0.000676	CcSEcCtD
Meloxicam—Rash—Etoposide—sarcoma	0.000119	0.000672	CcSEcCtD
Meloxicam—Dermatitis—Etoposide—sarcoma	0.000119	0.000671	CcSEcCtD
Meloxicam—Headache—Etoposide—sarcoma	0.000118	0.000667	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—sarcoma	0.000118	0.000667	CcSEcCtD
Meloxicam—Tension—Doxorubicin—sarcoma	0.000118	0.000664	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—sarcoma	0.000118	0.000663	CcSEcCtD
Meloxicam—Malaise—Epirubicin—sarcoma	0.000117	0.00066	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—sarcoma	0.000117	0.000657	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—sarcoma	0.000117	0.000657	CcSEcCtD
Meloxicam—Syncope—Epirubicin—sarcoma	0.000116	0.000656	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—sarcoma	0.000116	0.000655	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—sarcoma	0.000116	0.000655	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—sarcoma	0.000116	0.000651	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—sarcoma	0.000115	0.000647	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—sarcoma	0.000114	0.000643	CcSEcCtD
Meloxicam—Cough—Epirubicin—sarcoma	0.000113	0.000638	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—sarcoma	0.000113	0.000638	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—sarcoma	0.000113	0.000634	CcSEcCtD
Meloxicam—Nausea—Etoposide—sarcoma	0.000112	0.000633	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—sarcoma	0.000112	0.000632	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—sarcoma	0.000111	0.000628	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—sarcoma	0.000111	0.000626	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—sarcoma	0.000111	0.000623	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—sarcoma	0.000111	0.000623	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—sarcoma	0.00011	0.000621	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00011	0.000619	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—sarcoma	0.000109	0.000615	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—sarcoma	0.000108	0.00061	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—sarcoma	0.000108	0.000609	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—sarcoma	0.000108	0.000608	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—sarcoma	0.000108	0.000607	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—sarcoma	0.000108	0.000606	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—sarcoma	0.000107	0.000602	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—sarcoma	0.000106	0.000598	CcSEcCtD
Meloxicam—Oedema—Epirubicin—sarcoma	0.000106	0.000597	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—sarcoma	0.000106	0.000597	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—sarcoma	0.000106	0.000595	CcSEcCtD
Meloxicam—Infection—Epirubicin—sarcoma	0.000105	0.000593	CcSEcCtD
Meloxicam—Cough—Doxorubicin—sarcoma	0.000105	0.000591	CcSEcCtD
Meloxicam—Shock—Epirubicin—sarcoma	0.000104	0.000587	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—sarcoma	0.000104	0.000587	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—sarcoma	0.000104	0.000586	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—sarcoma	0.000104	0.000585	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—sarcoma	0.000104	0.000584	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—sarcoma	0.000103	0.000583	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—sarcoma	0.000103	0.00058	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—sarcoma	0.000102	0.000577	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—sarcoma	0.000102	0.000576	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—sarcoma	0.000102	0.000576	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—sarcoma	0.000102	0.000574	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000102	0.000572	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—sarcoma	0.000101	0.000569	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—sarcoma	0.0001	0.000564	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—sarcoma	9.9e-05	0.000558	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—sarcoma	9.89e-05	0.000557	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—sarcoma	9.81e-05	0.000552	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—sarcoma	9.81e-05	0.000552	CcSEcCtD
Meloxicam—Infection—Doxorubicin—sarcoma	9.74e-05	0.000549	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—sarcoma	9.66e-05	0.000544	CcSEcCtD
Meloxicam—Shock—Doxorubicin—sarcoma	9.65e-05	0.000544	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—sarcoma	9.62e-05	0.000542	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—sarcoma	9.6e-05	0.000541	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—sarcoma	9.59e-05	0.00054	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—sarcoma	9.57e-05	0.000539	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—sarcoma	9.53e-05	0.000537	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—sarcoma	9.52e-05	0.000536	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—sarcoma	9.48e-05	0.000534	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—sarcoma	9.45e-05	0.000532	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—sarcoma	9.42e-05	0.000531	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—sarcoma	9.33e-05	0.000526	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—sarcoma	9.21e-05	0.000519	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—sarcoma	9.16e-05	0.000516	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—sarcoma	9.15e-05	0.000516	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—sarcoma	9.14e-05	0.000515	CcSEcCtD
Meloxicam—Constipation—Epirubicin—sarcoma	9.06e-05	0.000511	CcSEcCtD
Meloxicam—Pain—Epirubicin—sarcoma	9.06e-05	0.000511	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—sarcoma	8.93e-05	0.000503	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—sarcoma	8.87e-05	0.0005	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—sarcoma	8.81e-05	0.000496	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—sarcoma	8.74e-05	0.000493	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—sarcoma	8.73e-05	0.000492	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—sarcoma	8.72e-05	0.000491	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—sarcoma	8.67e-05	0.000488	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—sarcoma	8.63e-05	0.000486	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—sarcoma	8.53e-05	0.00048	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—sarcoma	8.47e-05	0.000477	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—sarcoma	8.46e-05	0.000476	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—sarcoma	8.42e-05	0.000474	CcSEcCtD
Meloxicam—Pain—Doxorubicin—sarcoma	8.39e-05	0.000472	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—sarcoma	8.39e-05	0.000472	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—sarcoma	8.38e-05	0.000472	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—sarcoma	8.38e-05	0.000472	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—sarcoma	8.08e-05	0.000455	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—sarcoma	8.02e-05	0.000452	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—sarcoma	7.81e-05	0.00044	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—sarcoma	7.79e-05	0.000439	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—sarcoma	7.75e-05	0.000437	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—sarcoma	7.75e-05	0.000437	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—sarcoma	7.6e-05	0.000428	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—sarcoma	7.5e-05	0.000422	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—sarcoma	7.25e-05	0.000409	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—sarcoma	7.23e-05	0.000407	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—sarcoma	7.04e-05	0.000396	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—sarcoma	7.01e-05	0.000395	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—sarcoma	6.94e-05	0.000391	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—sarcoma	6.74e-05	0.00038	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—sarcoma	6.71e-05	0.000378	CcSEcCtD
Meloxicam—Rash—Epirubicin—sarcoma	6.68e-05	0.000376	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—sarcoma	6.68e-05	0.000376	CcSEcCtD
Meloxicam—Headache—Epirubicin—sarcoma	6.64e-05	0.000374	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—sarcoma	6.49e-05	0.000365	CcSEcCtD
Meloxicam—Nausea—Epirubicin—sarcoma	6.3e-05	0.000355	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—sarcoma	6.24e-05	0.000351	CcSEcCtD
Meloxicam—Rash—Doxorubicin—sarcoma	6.18e-05	0.000348	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—sarcoma	6.18e-05	0.000348	CcSEcCtD
Meloxicam—Headache—Doxorubicin—sarcoma	6.14e-05	0.000346	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—sarcoma	5.83e-05	0.000328	CcSEcCtD
